Clinical Trials on Advance Illness Patients With OIC in Hong Kong
Total 23 results
-
The University of Hong KongCompletedParents of Children With CancerHong Kong
-
The University of Hong KongUnknownParents of Children With CancerHong Kong
-
The University of Hong KongCompletedResilience of Parents Having Children With CancerHong Kong
-
Chinese University of Hong KongUnknownEnhanced Recovery After Surgery for Laparoscopic Gastrectomy for Patients With Gastric CancerHong Kong
-
Boston Scientific CorporationActive, not recruitingChinese Patients Treated With Agent DCBTaiwan, Hong Kong, Singapore
-
AmgenActive, not recruitingAdvanced/Metastatic Solid Tumors With KRAS p.G12C MutationTaiwan, Hong Kong
-
Guangzhou University of Traditional Chinese MedicineChinese University of Hong KongUnknownBrain Ischemia | Hemiplegic Patients With Stroke | Image Science | Electrophysiology of Neuromuscular | Abdominal AcupunctureHong Kong, China
-
Samsung Medical CenterNational Taiwan University Hospital; Chulalongkorn University; Asan Medical Center and other collaboratorsCompletedPatients Treated With AlemtuzumabKorea, Republic of, China, Indonesia, Thailand, Taiwan
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
Samsung Medical CenterCompletedPatients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma | Patients Treated With Rituximab-CHOP or Rituximab-CVPKorea, Republic of, Malaysia, Singapore, China
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Taiho Oncology, Inc.CompletedBreast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR TumorsFrance, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research ServicesTerminatedOtitis Media in Patients With Tympanostomy TubesUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Estonia, Germany, Poland, Portugal, Puerto Rico
-
Axsome Therapeutics, Inc.Enrolling by invitationAlzheimer Disease | Agitation in Patients With Dementia of the Alzheimer's Type | Agitation, PsychomotorUnited States, Canada
-
Axsome Therapeutics, Inc.RecruitingAlzheimer Disease | Agitation | Agitation in Patients With Dementia of the Alzheimer's TypeUnited States, Puerto Rico
-
Axsome Therapeutics, Inc.CompletedAlzheimer Disease | Agitation in Patients With Dementia of the Alzheimer's Type | Agitation,PsychomotorUnited States, Australia
-
NantCell, Inc.TakedaTerminatedCancer | Pancreatic Cancer | Advanced Solid Tumors | Metastatic Cancer | Bone Metastases | Solid Tumors | Pancreas Cancer | Adenocarcinoma of the Pancreas | Oncology | Cancer of Pancreas | Metastatic Pancreatic Cancer | Metastases | Cancer of the Pancreas | Advanced Malignancy | Oncology Patients | Endocrine CancerItaly, Spain, United Kingdom, Belgium, Canada, Denmark, Romania, United States, Germany, Netherlands, Korea, Republic of, Russian Federation, Australia, Austria, Lithuania, Portugal, Greece, Poland, Switzerland, Serbia, Bulgaria, ... and more
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Bulgaria, Denmark, Estonia, Greece, Poland, Portugal, Puerto Rico, United Kingdom, Germany, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Belgium, Canada, Chile, Colombia, Croatia, Hungary, Mexico, Netherlands, Slovakia, Slovenia, Spain, Ireland
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeSpain, United States, Italy, United Kingdom, Hungary, France, Poland, Australia, Bulgaria, Czechia, South Africa
-
Novartis PharmaceuticalsRecruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationItaly, Spain, United States, France, Thailand, Malaysia, China, Germany, India, Turkey, Belgium, Argentina, Bulgaria, Netherlands, Hungary, Greece, Portugal, Austria, Singapore, Brazil, United Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Spain, Hungary, Italy, Canada, Czechia, South Africa, Poland, Bulgaria, France